Edgewise Therapeutics, Inc. (EWTX) Social Stream
EDGEWISE THERAPEUTICS INC (EWTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EWTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-06 | 3 | $34 | $30 | $31.666 | $10.94 | 189.45% |
| 2022-01-06 | 3 | $34 | $31 | $32.666 | $10.94 | 198.59% |
| 2022-02-25 | 3 | $34 | $31 | $32.333 | $10.94 | 195.55% |
| 2022-04-13 | 4 | $34 | $31 | $32 | $10.94 | 192.5% |
| 2022-05-11 | 4 | $32 | $30 | $31 | $10.94 | 183.36% |
| 2022-05-23 | 5 | $31 | $11 | $26.2 | $10.94 | 139.49% |
| 2022-08-10 | 5 | $31 | $5 | $25 | $10.94 | 128.52% |
| 2022-08-25 | 5 | $31 | $5 | $25 | $10.94 | 128.52% |
| 2022-11-04 | 5 | $31 | $5 | $24.8 | $10.94 | 126.69% |
| 2023-01-13 | 5 | $32 | $5 | $24.2 | $10.94 | 121.21% |
| 2023-02-23 | 4 | $32 | $5 | $24.2 | $10.94 | 121.21% |
| 2023-04-20 | 6 | $32 | $5 | $23.6 | $10.94 | 115.72% |
| 2023-08-11 | 6 | $32 | $5 | $23.666 | $10.94 | 116.33% |
| 2023-08-15 | 6 | $32 | $5 | $23.833 | $10.94 | 117.85% |
| 2023-11-09 | 5 | $32 | $25 | $27.6 | $10.94 | 152.29% |
| 2023-11-10 | 5 | $32 | $23 | $26.8 | $10.94 | 144.97% |
| 2023-11-15 | 5 | $32 | $23 | $26.4 | $10.94 | 141.32% |
The Trend in the Analyst Price Target
EWTX's average price target has moved down $0.6 over the prior 18 months.
EWTX reports an average of 213.95% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-11 | 6 | 32 | 5 | 23.833 | 9.515 | 150.48% |
| 2023-06-11 | 6 | 32 | 5 | 23.666 | 9.630 | 145.75% |
| 2023-08-11 | 6 | 32 | 5 | 23.666 | 6.710 | 252.7% |
| 2023-09-17 | 5 | 32 | 25 | 27.600 | 6.420 | 329.91% |
| 2023-11-15 | 5 | 32 | 23 | 26.400 | 6.560 | 302.44% |
EWTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
EWTX's average broker recommendation rating improved by 0.13 over the prior 19 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, EDGEWISE THERAPEUTICS INC's variance in analysts' estimates is lower than -1228.21% of them.
- To contextualize these metrics, consider that out of all US stocks, EDGEWISE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2031.99% of them.
- In the context of all US stocks, EDGEWISE THERAPEUTICS INC's number of analysts covering the stock is greater than 430.05% of them.
- In terms of how EDGEWISE THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 1635.71% of that group.
Stocks similar to EDGEWISE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RAIN, VERA, and DAWN.
View All Top Stocks by Price Target
Make investment decisions regarding EWTX using the data that counts. Try POWR Ratings for free.